ESLA
Price
$0.91
Change
+$0.05 (+5.81%)
Updated
Aug 15 closing price
Capitalization
32.91M
LEGN
Price
$37.50
Change
-$0.21 (-0.56%)
Updated
Aug 15 closing price
Capitalization
6.92B
99 days until earnings call
Interact to see
Advertisement

ESLA vs LEGN

Header iconESLA vs LEGN Comparison
Open Charts ESLA vs LEGNBanner chart's image
Estrella Immunopharma
Price$0.91
Change+$0.05 (+5.81%)
Volume$20K
Capitalization32.91M
Legend Biotech
Price$37.50
Change-$0.21 (-0.56%)
Volume$869.11K
Capitalization6.92B
ESLA vs LEGN Comparison Chart in %
Loading...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLA vs. LEGN commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLA is a Hold and LEGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (ESLA: $0.91 vs. LEGN: $37.50)
Brand notoriety: ESLA and LEGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ESLA: 109% vs. LEGN: 61%
Market capitalization -- ESLA: $32.91M vs. LEGN: $6.92B
ESLA [@Biotechnology] is valued at $32.91M. LEGN’s [@Biotechnology] market capitalization is $6.92B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLA’s FA Score shows that 0 FA rating(s) are green whileLEGN’s FA Score has 0 green FA rating(s).

  • ESLA’s FA Score: 0 green, 5 red.
  • LEGN’s FA Score: 0 green, 5 red.
According to our system of comparison, LEGN is a better buy in the long-term than ESLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLA’s TA Score shows that 5 TA indicator(s) are bullish while LEGN’s TA Score has 5 bullish TA indicator(s).

  • ESLA’s TA Score: 5 bullish, 3 bearish.
  • LEGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ESLA is a better buy in the short-term than LEGN.

Price Growth

ESLA (@Biotechnology) experienced а +10.57% price change this week, while LEGN (@Biotechnology) price change was +1.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

LEGN is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($6.92B) has a higher market cap than ESLA($32.9M). LEGN YTD gains are higher at: 15.243 vs. ESLA (-24.167). ESLA has higher annual earnings (EBITDA): -8.82M vs. LEGN (-153.44M). LEGN has more cash in the bank: 1.01B vs. ESLA (421K). LEGN has higher revenues than ESLA: LEGN (728M) vs ESLA (0).
ESLALEGNESLA / LEGN
Capitalization32.9M6.92B0%
EBITDA-8.82M-153.44M6%
Gain YTD-24.16715.243-159%
P/E RatioN/AN/A-
Revenue0728M-
Total Cash421K1.01B0%
Total DebtN/A363M-
TECHNICAL ANALYSIS
Technical Analysis
ESLALEGN
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
53%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
42%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
40%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 27 days ago
74%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
49%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
CHFAUD1.91N/A
N/A
Switzerland Franc - Australian Dollar
EURAUD1.79N/A
N/A
Euro - Australian Dollar
JPYCAD0.01N/A
N/A
Japan Yen - Canadian Dollar
XAGUSD38.00N/A
N/A
Silver Ounce - United States Dollar
WBCRX16.67-0.08
-0.48%
William Blair Small-Mid Cap Core R6

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and CARM have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and CARM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+5.76%
CARM - ESLA
25%
Poorly correlated
+2.35%
FATE - ESLA
23%
Poorly correlated
+1.87%
CMND - ESLA
23%
Poorly correlated
+0.98%
LEGN - ESLA
22%
Poorly correlated
-0.56%
PSTV - ESLA
22%
Poorly correlated
+15.81%
More

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with TRDA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
-0.56%
TRDA - LEGN
37%
Loosely correlated
+0.38%
XNCR - LEGN
35%
Loosely correlated
+0.39%
ZLAB - LEGN
34%
Loosely correlated
+2.29%
CRSP - LEGN
34%
Loosely correlated
+1.55%
ACIU - LEGN
34%
Loosely correlated
N/A
More